We are engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (“SCA”) and clinical research. Our ICELL8™ Single-Cell System is a cutting edge platform that can isolate thousands of single cells and process specific cells for analysis including Next Generation Sequencing (“NGS”). We believe ICELL8s introduction into the rapidly growing SCA market will revolutionize biopharma, diagnostics and life science research. ICELL8 is based upon our SmartChip platform which is also used for profiling and validating molecular biomarkers. SmartChip can perform massively parallel singleplex PCR for one-step target enrichment and library preparation for clinical NGS. Our Apollo 324™ system can be used to process DNA and RNA from clinical samples to NGS-ready libraries. Our SmartChip and Apollo product lines are aimed at researchers performing genetic analyses in the life sciences, pharmaceutical and biotech drug discovery, diagnostics and clinical laboratory industries. WaferGen’s technology solutions are potent tools for the discovery and validation of clinically relevant disease biomarkers, clinical tests and new drug therapies.
Company profile
Ticker
WGBS
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
La Burbuja Cafe, Inc.
SEC CIK
Corporate docs
IRS number
900416683
Latest filings (excl ownership)
15-12G
Securities registration termination
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POSASR
Automatic shelf registration (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
Latest ownership filings
4
JOEL S KANTER
1 Mar 17
4
Michael P Henighan
1 Mar 17
4
Robert Alan Schueren
1 Mar 17
4
IVAN TRIFUNOVICH
1 Mar 17
4
R Dean Hautamaki
1 Mar 17
4
William Douglas McKenzie
1 Mar 17
4
Makoto Kaneshiro
1 Mar 17
4
Rolland Carlson
1 Mar 17
SC 13G/A
WaferGen Bio-systems, Inc.
23 Feb 17
SC 13G/A
WaferGen Bio-systems, Inc.
6 Jan 17
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|